Q8VHI6
Gene name |
Wasf3 (Wave3) |
Protein name |
Actin-binding protein WASF3 |
Names |
Protein WAVE-3, Wiskott-Aldrich syndrome protein family member 3, WASP family protein member 3 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:245880 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8VHI6
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8VHI6-F1 | Predicted | AlphaFoldDB |
36 variants for Q8VHI6
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3388804190 | 37 | I>M | No | EVA | |
| rs3388801140 | 93 | Q>K | No | EVA | |
| rs3388799453 | 103 | S>G | No | EVA | |
| rs3388810971 | 135 | S>I | No | EVA | |
| rs3388791316 | 147 | G>R | No | EVA | |
| rs3395640322 | 249 | S>FL* | No | EVA | |
| rs3388791327 | 250 | Y>C | No | EVA | |
| rs3396110622 | 250 | Y>F | No | EVA | |
| rs3395640322 | 250 | Y>F | No | EVA | |
| rs3396110622 | 250 | Y>FL* | No | EVA | |
| rs3396339809 | 262 | P>Q | No | EVA | |
| rs214887380 | 263 | A>V | No | EVA | |
| rs3388799469 | 266 | S>F | No | EVA | |
| rs1133249722 | 281 | G>C | No | EVA | |
| rs1132468871 | 282 | A>T | No | EVA | |
| rs1133658915 | 287 | R>* | No | EVA | |
| rs1132876911 | 288 | P>L | No | EVA | |
| rs1132208183 | 289 | S>P | No | EVA | |
| rs1135143513 | 292 | S>L | No | EVA | |
| rs1133409414 | 311 | Q>* | No | EVA | |
| rs1133033592 | 313 | P>L | No | EVA | |
| rs1134458924 | 316 | S>F | No | EVA | |
| rs1134285092 | 319 | S>F | No | EVA | |
| rs1133613304 | 320 | T>K | No | EVA | |
| rs3388805057 | 334 | I>K | No | EVA | |
| rs3388817592 | 355 | A>S | No | EVA | |
| rs257173936 | 367 | T>A | No | EVA | |
| rs3388791358 | 375 | A>T | No | EVA | |
| rs3388779997 | 376 | V>I | No | EVA | |
| rs221258608 | 380 | P>S | No | EVA | |
| rs264119070 | 414 | S>T | No | EVA | |
| rs3388810401 | 467 | E>D | No | EVA | |
| rs3388801144 | 481 | I>T | No | EVA | |
| rs49378137 | 493 | E>A | No | EVA | |
| rs3396410943 | 501 | D>A | No | EVA | |
| rs3396339743 | 502 | D>E | No | EVA |
No associated diseases with Q8VHI6
4 regional properties for Q8VHI6
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| repeat | WD40 repeat | 227 - 264 | IPR001680-1 |
| repeat | WD40 repeat | 269 - 304 | IPR001680-2 |
| repeat | WD40 repeat | 349 - 390 | IPR001680-3 |
| domain | BING4, C-terminal domain | 441 - 519 | IPR012952 |
6 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoskeleton | A cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. |
| glial cell projection | A prolongation or process extending from a glial cell. |
| glutamatergic synapse | A synapse that uses glutamate as a neurotransmitter. |
| lamellipodium | A thin sheetlike process extended by the leading edge of a migrating cell or extending cell process; contains a dense meshwork of actin filaments. |
| postsynapse | The part of a synapse that is part of the post-synaptic cell. |
| SCAR complex | A pentameric complex that includes orthologues of human PIR121, Nap1, Abi, SCAR, and HSPC300 and regulates actin polymerization and/or depolymerization through small GTPase mediated signal transduction. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| actin binding | Binding to monomeric or multimeric forms of actin, including actin filaments. |
| Arp2/3 complex binding | Binding to an Arp2/3 complex, a protein complex that contains two actin-related proteins, Arp2 and Arp3, and five novel proteins (ARPC1-5). |
| protein kinase A regulatory subunit binding | Binding to one or both of the regulatory subunits of protein kinase A. |
8 GO annotations of biological process
| Name | Definition |
|---|---|
| actin cytoskeleton organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins. |
| cytoskeleton organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures. |
| lamellipodium assembly | Formation of a lamellipodium, a thin sheetlike extension of the surface of a migrating cell. |
| modification of postsynaptic actin cytoskeleton | Any process that modifies the structure of a postsynaptic actin cytoskeleton. |
| oligodendrocyte development | The process aimed at the progression of an oligodendrocyte over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. An oligodendrocyte is a type of glial cell involved in myelinating the axons in the central nervous system. |
| positive regulation of Arp2/3 complex-mediated actin nucleation | Any process that activates or increases the frequency, rate or extent of Arp2/3 complex-mediated actin nucleation. |
| positive regulation of myelination | Any process that activates or increases the frequency, rate or extent of the formation of a myelin sheath around nerve axons. |
| regulation of cell shape | Any process that modulates the surface configuration of a cell. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MPLVKRNIEP | RHLCRGALPE | GVTSELECVT | NSTLAAIIRQ | LSSLSKHAED | IFGELFNEAN |
| 70 | 80 | 90 | 100 | 110 | 120 |
| NFYIRANSLQ | DRIDRLAVKV | TQLDSTVEEV | SLQDINMKKA | FKSSTIQDQQ | VVSKNSIPNP |
| 130 | 140 | 150 | 160 | 170 | 180 |
| VADIYNQSDK | PPPLSILTPY | RDDKKDGLKF | YTDPSYFFDL | WKEKMLQDTE | DKRKEKRRQK |
| 190 | 200 | 210 | 220 | 230 | 240 |
| EQKRVDGTTR | EVKKVRKARN | RRQEWNMMAY | DKELRPDNRL | SQSVHHGASS | EGSLSPDTRS |
| 250 | 260 | 270 | 280 | 290 | 300 |
| HTSDVTDYSY | PATPNHALQA | QPATPSYTAG | DAPLHGTTNQ | GAEHEYRPSS | ASARHMALNR |
| 310 | 320 | 330 | 340 | 350 | 360 |
| PQQPPPPPPP | QAPEGSQAST | SVAPADYGML | PAQIIEYYSP | SGPPPPPPPP | MIPSAQTAFV |
| 370 | 380 | 390 | 400 | 410 | 420 |
| SPLQMPTQPP | FPASAVSTYP | TPPHQPSTGL | LATAPPPPGP | PPPPPGPPGP | SSLSSSPMHG |
| 430 | 440 | 450 | 460 | 470 | 480 |
| PPVAEAKRPE | PAQPPISDAR | SDLLAAIRMG | IQLKKVQEQR | EQEAKREPVG | NDVATILSRR |
| 490 | 500 | ||||
| IAVEYSDSDD | DSEFDENDWS | D |